Literature DB >> 28204906

Differential Brain, Cognitive and Motor Profiles Associated with Partial Trisomy. Modeling Down Syndrome in Mice.

Pierre L Roubertoux1, Nathalie Baril2, Pierre Cau3,4,5, Christophe Scajola3, Adeline Ghata3, Catherine Bartoli3, Patrice Bourgeois3,4, Julie di Christofaro6, Sylvie Tordjman7,8, Michèle Carlier9.   

Abstract

We hypothesize that the trisomy 21 (Down syndrome) is the additive and interactive outcome of the triple copy of different regions of HSA21. Because of the small number of patients with partial trisomy 21, we addressed the question in the Mouse in which three chromosomal regions located on MMU10, MMU17 and MMU16 carries almost all the HSA21 homologs. Male mice from four segmental trisomic strains covering the D21S17-ETS2 (syntenic to MMU16) were examined with an exhaustive battery of cognitive tests, motor tasks and MRI and compared with TS65Dn that encompasses D21S17-ETS2. None of the four strains gather all the impairments (measured by the effect size) of TS65Dn strain. The 152F7 strain was close to TS65Dn for motor behavior and reference memory and the three other strains 230E8, 141G6 and 285E6 for working memory. Episodic memory was impaired only in strain 285E6. The hippocampus and cerebellum reduced sizes that were seen in all the strains indicate that trisomy 21 is not only a hippocampus syndrome but that it results from abnormal interactions between the two structures.

Entities:  

Keywords:  Cognition; D21S17-ETS2 region; Effect size; MRI; Protein–protein interactions; Trisomy 21

Mesh:

Year:  2017        PMID: 28204906     DOI: 10.1007/s10519-017-9835-5

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  9 in total

1.  Age- and speed-dependent modulation of gaits in DSCAM2J mutant mice.

Authors:  Louise Thiry; Maxime Lemieux; Frédéric Bretzner
Journal:  J Neurophysiol       Date:  2017-11-01       Impact factor: 2.714

Review 2.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 3.  Hippocampal deficits in neurodevelopmental disorders.

Authors:  Yue Li; Minjie Shen; Michael E Stockton; Xinyu Zhao
Journal:  Neurobiol Learn Mem       Date:  2018-10-12       Impact factor: 2.877

4.  Everyday Memory in People with Down Syndrome.

Authors:  Yingying Yang; Zachary M Himmelberger; Trent Robinson; Megan Davis; Frances Conners; Edward Merrill
Journal:  Brain Sci       Date:  2021-04-27

5.  A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay.

Authors:  Kyu-Sun Lee; Miri Choi; Dae-Woo Kwon; Doyoun Kim; Jong-Moon Choi; Ae-Kyeong Kim; Youngwook Ham; Sang-Bae Han; Sungchan Cho; Chong Kun Cheon
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

6.  Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.

Authors:  Thu Lan Nguyen; Arnaud Duchon; Antigoni Manousopoulou; Nadège Loaëc; Benoît Villiers; Guillaume Pani; Meltem Karatas; Anna E Mechling; Laura-Adela Harsan; Emmanuelle Limanton; Jean-Pierre Bazureau; François Carreaux; Spiros D Garbis; Laurent Meijer; Yann Herault
Journal:  Dis Model Mech       Date:  2018-09-27       Impact factor: 5.758

7.  Targeted Tshz3 deletion in corticostriatal circuit components segregates core autistic behaviors.

Authors:  Xavier Caubit; Paolo Gubellini; Pierre L Roubertoux; Michèle Carlier; Jordan Molitor; Dorian Chabbert; Mehdi Metwaly; Pascal Salin; Ahmed Fatmi; Yasmine Belaidouni; Lucie Brosse; Lydia Kerkerian-Le Goff; Laurent Fasano
Journal:  Transl Psychiatry       Date:  2022-03-15       Impact factor: 7.989

8.  A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.

Authors:  Mathieu Milh; Pierre Roubertoux; Najoua Biba; Julie Chavany; Adeline Spiga Ghata; Camille Fulachier; Stephan Christopher Collins; Christel Wagner; Jean-Christophe Roux; Binnaz Yalcin; Marie-Solenne Félix; Florence Molinari; Pierre-Pascal Lenck-Santini; Laurent Villard
Journal:  Epilepsia       Date:  2020-04-02       Impact factor: 5.864

Review 9.  DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome.

Authors:  Anis Feki; Youssef Hibaoui
Journal:  Brain Sci       Date:  2018-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.